New positive inotropic agent OPC-8212 modulates single Ca2+ channels in ventricular myocytes of guinea pig

Journal of Cardiovascular Pharmacology
A YataniA M Brown

Abstract

The effects of a new positive inotropic drug, OPC-8212 (a quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1 -piperazinyl]-2(1H)-quinolinone), on whole-cell and single-channel calcium currents of guinea pig ventricular myocytes were studied by the patch-clamp method. OPC-8212 increased whole-cell calcium currents in a concentration-dependent manner. The concentration-response curve was fitted by a single binding site model that has an ED50 of 2.7 microM. At the single-channel level, OPC-8212 increased calcium currents mainly by increasing the probability of channel opening on depolarization; the open times were slightly increased, but single-channel conductance did not change. The actions of OPC-8212 on single calcium channel currents were compared with those of forskolin, isoproterenol, and caffeine, agents that cause positive inotropic effects associated with an increase in cytoplasmic cyclic AMP level, and with those of the dihydropyridine calcium channel agonist (-)Bay K 8644, an agent that has a positive inotropic effect but does not act through cyclic AMP. OPC-8212 increased calcium currents in a manner that resembled the actions of forskolin, isoproterenol, and caffeine rather than the actions of (-)Bay K ...Continue Reading

Citations

Sep 1, 1995·Clinical Cardiology·A M FeldmanS Murali
Dec 1, 1988·Cardiovascular Drugs and Therapy·S H KuboJ N Cohn
Oct 1, 1993·Journal of the American College of Cardiology·A M Feldman
Jul 15, 1993·The New England Journal of Medicine·A M FeldmanR P Bain
Oct 1, 1993·Parasitology Today·M Röcken, E M Shevach
Dec 1, 1996·Journal of Cardiac Failure·J ToyamaI Kodama
Jun 1, 1995·Journal of Cardiac Failure·E CavusogluM Klapholz
Nov 13, 1998·American Heart Journal·M Scherrer-CrosbieM H Picard
Jan 10, 2004·Journal of Neurochemistry·Takashi YonedaYoshihiko Funae
Aug 6, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Shigetake Sasayama
Feb 9, 2013·Molecular Pharmacology·Kentaro HottaHiroshi Handa
Jan 16, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Kenji TsujimaeYoshihisa Kurachi
Apr 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·D A LathropA Schwartz
Aug 1, 1996·Current Problems in Cardiology·C V Leier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.